SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-19-000795
Filing Date
2019-03-27
Accepted
2019-03-27 17:11:14
Documents
66
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K phio_10k-123118.htm 10-K 791601
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM phio_10k-ex2301.htm EX-23.1 2015
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL phio_10k-ex3101.htm EX-31.1 8863
4 CERTIFICATION phio_10k-ex3201.htm EX-32.1 3769
5 GRAPHIC image_001.jpg GRAPHIC 165240
6 GRAPHIC image_002.jpg GRAPHIC 32165
  Complete submission text file 0001683168-19-000795.txt   3597799

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE phio-20181231.xml EX-101.INS 409527
8 XBRL SCHEMA FILE phio-20181231.xsd EX-101.SCH 34298
9 XBRL CALCULATION FILE phio-20181231_cal.xml EX-101.CAL 53671
10 XBRL DEFINITION FILE phio-20181231_def.xml EX-101.DEF 171223
11 XBRL LABEL FILE phio-20181231_lab.xml EX-101.LAB 298971
12 XBRL PRESENTATION FILE phio-20181231_pre.xml EX-101.PRE 248750
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 19709059
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences